rs141845482
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000082.4(ERCC8):c.1012G>A(p.Asp338Asn) variant causes a missense change. The variant allele was found at a frequency of 0.00073 in 1,613,318 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000082.4 missense
Scores
Clinical Significance
Conservation
Publications
- Cockayne syndrome type 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, PanelApp Australia, ClinGen, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P
- UV-sensitive syndrome 2Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- Cockayne syndrome type 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- UV-sensitive syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERCC8 | NM_000082.4 | c.1012G>A | p.Asp338Asn | missense_variant | Exon 10 of 12 | ENST00000676185.1 | NP_000073.1 | |
| ERCC8 | NM_001007233.3 | c.838G>A | p.Asp280Asn | missense_variant | Exon 11 of 13 | NP_001007234.1 | ||
| ERCC8 | NM_001290285.2 | c.553G>A | p.Asp185Asn | missense_variant | Exon 9 of 11 | NP_001277214.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERCC8 | ENST00000676185.1 | c.1012G>A | p.Asp338Asn | missense_variant | Exon 10 of 12 | NM_000082.4 | ENSP00000501614.1 |
Frequencies
GnomAD3 genomes AF: 0.000618 AC: 94AN: 152172Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.000379 AC: 95AN: 250956 AF XY: 0.000413 show subpopulations
GnomAD4 exome AF: 0.000741 AC: 1083AN: 1461146Hom.: 2 Cov.: 32 AF XY: 0.000724 AC XY: 526AN XY: 726910 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000618 AC: 94AN: 152172Hom.: 0 Cov.: 33 AF XY: 0.000538 AC XY: 40AN XY: 74330 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
BP4 -
The D338N variant in the ERCC8 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. Although not observed in the homozygous state, the D338N variant is observed in 101/126354 (0.080%) alleles from individuals of non-Finnish European background and 113/276718 (0.041%) total alleles in large population cohorts (Lek et al., 2016). The D338N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. We interpret D338N as a variant of uncertain significance. -
This sequence change replaces aspartic acid, which is acidic and polar, with asparagine, which is neutral and polar, at codon 338 of the ERCC8 protein (p.Asp338Asn). This variant is present in population databases (rs141845482, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with ERCC8-related conditions. ClinVar contains an entry for this variant (Variation ID: 546240). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt ERCC8 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
ERCC8: BS1 -
Cockayne syndrome type 1 Uncertain:1
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Cockayne syndrome type 1;C3553298:UV-sensitive syndrome 2 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at